CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
86,956,355
Share change
+508,199
Total reported value
$916,510,248
Put/Call ratio
461%
Price per share
$10.54
Number of holders
157
Value change
-$58,242,771
Number of buys
87
Number of sells
82

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q3 2015

As of 30 Sep 2015, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,956,355 shares. The largest 10 holders included FMR LLC, OPPENHEIMER FUNDS INC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, FRONTIER CAPITAL MANAGEMENT CO LLC, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 157 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.